Decision making in non-AIDS-defining malignancies

The Lancet Oncology

Volumn 13, Issue 12, 2012, Pages 1172-1173

  Aboulafia, David M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; VARENICLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; DEATH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LETTER; LONGEVITY; LUNG CANCER; LUNG CARCINOGENESIS; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; NON AIDS DEFINING MALIGNANCY; NONHODGKIN LYMPHOMA; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING CESSATION; UNSPECIFIED SIDE EFFECT;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARCINOMA, NON-SMALL-CELL LUNG; HIV INFECTIONS; HUMANS; LUNG NEOPLASMS;

EID: 84870242820     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70520-X     Document Type: Letter

References (11)

1. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987, 317:1297-1302.
2. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA Immune deficiency and risk for malignancy among persons with AIDS. JAIDS 2003, 32:527-533.
3. Justice AC HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010, 7:69-76.
4. Deeks PA HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009, 338:a3172.
5. Shiels MS, Cole SR, Kirk GD, Poole C A meta-analysis of the incidence of non-AIDs defining cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009, 52:611-622.
6. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS defining cancers in people with HIV infection. J Clin Oncol 2009, 27:884-890.
7. D'Jaen GA, Pantanowitz L, Bower M, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a mult-institutional collaboration. Clin Lung Cancer 2010, 11:396-404.
8. Rengan R, Mitra N, Liao K, Armstrong K, Vachani A Effect of HIV in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol 2012, published online Nov 16. http://dx.doi.org/10.1016/S1470-2045(12)70466-7.
9. Persad GC, Little RF, Grady C Including persons with HIV infection in cancer clinical trials. J Clin Oncol 2008, 26:1027-1032.
10. Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis 2012, 55:1228-1235.
11. Rudek MA, Flexner C, Ambinder RF Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol 2011, 12:905-912.